Matrix metalloproteinases 2 and 9 increase permeability of sheep pleura in vitro

BMC Physiology

Volumn 12, Issue 1, 2012, Pages

  Apostolidou, Eleni ^a   Paraskeva, Efrosyni ^a   Gourgoulianis, Konstantinos ^a   Molyvdas, Paschalis Adam ^a   Hatzoglou, Chrissi ^a  

^a UNIVERSITY OF THESSALY   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B;

ANIMAL; ARTICLE; DRUG EFFECT; IN VITRO STUDY; PERMEABILITY; PHYSIOLOGY; PLEURA; SHEEP;

ANIMALS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PERMEABILITY; PLEURA; SHEEP;

EID: 84858186377     PISSN: None     EISSN: 14726793     Source Type: Journal    
DOI: 10.1186/1472-6793-12-2     Document Type: Article

References (32)

1. Matrix turnover. Kerrigan JJ, Kerrigan JJ, Mansell JP, Sandy JR, J Orthod 2000 27 227 233 11099555
2. Structure and function of matrix metalloproteinases and timps. Nagase H, Visse R, Murphy G, Cardiovasc Res 2006 69 562 573 10.1016/j.cardiores.2005.12. 002 16405877 (Pubitemid 43139720)
3. MMP and TIMP expression pattern in pleural effusions of different origins. Eickelberg O, Sommerfeld CO, Wyser C, Tamm M, Reichenberger F, Bardin PG, Soler M, Roth M, Perruchoud AP, Am J Respir Crit Care Med 1997 156 1987 1992 9412584 (Pubitemid 28011811)
4. Increased amounts of collagenase and gelatinase in porcine myocardium following ischemia and reperfusion. Danielsen CC, Wiggers H, Andersen HR, J Mol Cell Cardiol 1998 30 1431 1442 10.1006/jmcc.1998.0711 9710810 (Pubitemid 28345043)
5. Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier. Giebel SJ, Menicucci G, McGuire PG, Das A, Lab Invest 2005 85 597 607 10.1038/labinvest.3700251 15711567 (Pubitemid 40675441)
6. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Rosenberg GA, Estrada EY, Dencoff JE, Stroke 1998 29 2189 2195 10.1161/01.STR.29.10.2189 9756602 (Pubitemid 28443538)
7. Tyrosine phosphatase inhibition induces loss of blood-brain barrier integrity by matrix metalloproteinase-dependent and -independent pathways. Lohmann C, Krischke M, Wegener J, Galla HJ, Brain Res 2004 995 184 196 10.1016/j.brainres.2003.10.002 14672808 (Pubitemid 37522019)
8. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. Yang Y, Estrada EY, Thompson JF, Liu W, Rosenberg GA, J Cereb Blood Flow Metab 2007 27 697 709 16850029 (Pubitemid 46474608)
9. The tight junction: a multifunctional complex. Schneeberger EE, Lynch RD, Am J Physiol Cell Physiol 2004 286 1213 C1228 10.1152/ajpcell.00558.2003 15151915 (Pubitemid 38649971)
10. Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions. Iglesias D, Alegre J, Aleman C, Ruiz E, Soriano T, Armadans LI, Segura RM, Angles A, Monasterio J, de Sevilla TF, Eur Respir J 2005 25 104 109 10.1183/09031936.04.00010504 15640330 (Pubitemid 40207738)
11. Potential role of matrix metalloproteinase-2,-9 and tissue inhibitors of metalloproteinase-1,-2 in exudative pleural effusions. Vatansever S, Gelisgen R, Uzun H, Yurt S, Kosar F, Clin Invest Med 2009 32 293 E300 20003835
12. Metalloproteinases and tissue inhibitor of metalloproteinases in mesothelial cells. Cellular differentiation influences expression. Marshall BC, Santana A, Xu QP, Petersen MJ, Campbell EJ, Hoidal JR, Welgus HG, J Clin Invest 1993 91 1792 1799 10.1172/JCI116390 8386195 (Pubitemid 23127386)
13. Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors. Arribas J, Coodly L, Vollmer P, Kishimoto TK, Rose-John S, Massague J, J Biol Chem 1996 271 11376 11382 10.1074/jbc.271.19. 11376 8626692 (Pubitemid 26155976)
14. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. McQuibban GA, Gong JH, Tam EM, McCulloch CA, Clark-Lewis I, Overall CM, Science 2000 289 1202 1206 10.1126/science.289.5482. 1202 10947989 (Pubitemid 30650734)
15. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. Woessner F Jr, Faseb 1991 5 2145 2154
16. Matrix metalloproteinases and their inhibitorsin tumour growth and invasion. Kahari VM, Saarialho-Kere U, Ann Med 1999 31 34 45 10.3109/07853899909019260 10574153 (Pubitemid 29134483)
17. Tissue inhibitors of metalloproteinases and their cell growth- promoting activity. Hayakawa T, Cell Struct Funct 1994 19 109 114 10.1247/csf.19.109 7954870 (Pubitemid 24226004)
18. Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). Hayakawa T, Yamashita K, Ohuchi E, Shinagawa A, J Cell Sci 1994 107 2373 2379 7844157 (Pubitemid 24292486)
19. Possible involvement of phosphorylation of occludin in tight junction formation. Sakakibara A, Furuse M, Saitou M, Ando-Akatsuka Y, Tsukita S, J Cell Biol 1997 137 1393 1401 10.1083/jcb.137.6.1393 9182670 (Pubitemid 27265950)
20. Regulation of tight junctions and loss of barrier function in pathophysiology. Harhaj NS, Antonetti DA, Int J Biochem Cell Biol 2004 36 1206 1237 10.1016/j.biocel.2003.08.007 15109567 (Pubitemid 38519069)
21. Increased matrix metalloproteinase 9 activity and mRNA expression in lung ischemia-reperfusion injury. Yano M, Omoto Y, Yamakawa Y, Nakashima Y, Kiriyama M, Saito Y, Fujii Y, J Heart Lung Transplant 2001 20 679 686 10.1016/S1053-2498(01)00250-9 11404174 (Pubitemid 32515209)
22. Ischemia-induced cleavage of cadherins in NRK cells requires MT1-MMP (MMP-14). Covington MD, Burghardt RC, Parrish AR, Am J Physiol Renal Physiol 2006 290 43 F51 16077081
23. Disruptions of occludin and claudin-5 in brain endothelial cells in vitro and in brains of mice with acute liver failure. Chen F, Ohashi N, Li W, Eckman C, Nguyen JH, Hepatology 2009 50 1914 1923 10.1002/hep.23203 19821483
24. Focal cerebral ischemia reduces active proteases that degrade microvascular matrix. Fukuda S, Fini CA, Mabuchi T, Koziol JA, Eggleston LL Jr, del Zoppo GJ, Stroke 2004 35 998 1004 10.1161/01.STR.0000119383.76447.05 15001799 (Pubitemid 38419817)
25. Evaluation of basement membrane degradation during TNF-alpha-induced increase in epithelial permeability. Lacherade JC, Van De Louw A, Planus E, Escudier E, D' Ortho MP, Lafuma C, Harf A, Delclaux C, Am J Physiol Lung Cell Mol Physiol 2001 281 134 L143 11404256
26. Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes. Navaratna D, McGuire PG, Menicucci G, Das A, Diabetes 2007 56 2380 2387 10.2337/db06-1694 17536065 (Pubitemid 47358245)
27. Macromolecule transfer through mesothelium and connective tissue. Bodega F, Zocchi L, Agostoni E, J Appl Physiol 2000 89 2165 2173 11090563
28. Equivalent radius of paracellular "pores" of the mesothelium. Agostoni E, Bodega F, Zocchi L, J Appl Physiol 1999 87 538 544 10444610 (Pubitemid 29374987)
29. Immunobiology of pleural inflammation: potentialimplications for pathogenesis, diagnosis and therapy. Kroegel C, Antony VB, Eur Respir J 1997 10 2411 2418 10.1183/09031936.97.10102411 9387973 (Pubitemid 27479569)
30. Immunological mechanisms in pleural disease. Antony VB, Eur Respir J 2003 21 539 544 10.1183/09031936.03.00403902 12662014 (Pubitemid 36336217)
31. The pleura: a combined light microscopic and scanning and transmission electron microscopic study in the sheep. II. Response to injury. Wheeldon EB, Mariassy AT, McSporran KD, Exp Lung Res 1983 5 125 140 10.3109/01902148309061509 6628347 (Pubitemid 13020848)
32. Isolation, culture and characterization of human peritoneal mesothelial cells. Stylianou E, Jenner LA, Davies M, Coles GA, Williams JD, Kidney Int 1990 37 1563 1570 10.1038/ki.1990.150 2362409 (Pubitemid 20198041)